SecBot SecBot
Home › SEC Filings

SEC Filing Analysis

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
VISMSC 13D/Aneutral3/10Paul R. Taylor files this Amendment No. 1 to his Schedule 13D to correct and withdraw his prior filing. He states that tOct 28, 2026
FLEXPRESS-RELEASEbullish6/10Flex reported Q2 FY2027 adjusted EPS of $1.18, beating the $1.06 consensus by 11.3%, and revenue of $8.5B, above the $8.Oct 28, 2026
REPL8-Kneutral5/10Replimune reported fiscal Q2 2027 results with a net loss of $57.1M ($0.54 per share), narrower than the $83.1M loss in Oct 28, 2026
MLYSPRESS-RELEASEbullish6/10Mineralys Therapeutics announced positive Phase 2 Explore-CKD results for lorundrostat, published in Kidney InternationaOct 28, 2026
AMRN8-Kneutral5/10Amarin reported Q3 2026 GAAP net income of $0.2M, its first profitable quarter in over two years, versus a net loss of $Oct 28, 2026
OTLY6-Kbearish5/10Oatly reported Q3 2026 revenue of $243.1M, up 9.1% YoY, and an operating loss of $9.2M, a significant improvement from aOct 28, 2026
QBTS8-Kneutral3/10D-Wave Quantum Inc. announced a non-binding MOU with LG CNS to advance quantum computing adoption for enterprise optimizOct 28, 2026
TEX8-Kbullish6/10Terex reported Q3 2026 adjusted EPS of $1.50, beating the $1.42 consensus by 5.6%, on pro forma revenue growth of 11.6% Oct 28, 2026
AXGN8-Kbullish6/10Axogen reported Q3 2026 revenue of $75.8M (+26.2% YoY), above the $73.2M consensus, and GAAP net income of $2.3M ($0.04 Oct 28, 2026
HAYW8-Kbullish6/10Hayward Holdings reported Q3 fiscal 2026 results with net sales up 6% YoY to $260.1M and adjusted diluted EPS up 29% to Oct 28, 2026
SCLPRESS-RELEASEneutral2/10Stepan Company declared a Q4 2026 quarterly cash dividend of $0.405 per share, a $0.01 increase from the prior quarter, Oct 28, 2026
OTLY6-Kbearish6/10Oatly reported Q3 2026 revenue of $243.1M (+9.1% YoY), in line with the $243.5M consensus, and a GAAP net loss per ADS oOct 28, 2026
DBDPRESS-RELEASEneutral3/10Diebold Nixdorf announced a new $250 million share repurchase program, replacing a nearly completed $200 million programOct 28, 2026
GNPX8-Kneutral2/10Genprex announced that research from its sponsored collaboration with Meharry Medical College on the TUSC2 gene therapy Oct 28, 2026
STGSC 13G/Aneutral2/10AREO Holdings Ltd and affiliated Orchid Asia entities filed an amended Schedule 13G for Sunlands Technology Group, disclOct 28, 2026
AEBIPRESS-RELEASEneutral2/10Aebi Schmidt Group announced a quarterly dividend of $0.025 per share and scheduled its Q3 2026 earnings call for NovembOct 28, 2026
QH6-Kneutral2/10Quhuo Limited disclosed that its affiliate, Beijing Quhuo Technology, entered into a credit facility agreement with XiamOct 28, 2026
DDI6-Kneutral2/10DoubleDown Interactive announced it will release Q3 2026 results on November 11, 2026, and host a conference call the saOct 28, 2026
BLCO8-Kbullish6/10Bausch + Lomb reported Q3 2026 revenue of $1.375B (+7% YoY) and GAAP net income of $32M, swinging from a $28M loss a yeaOct 28, 2026
GLDG6-Kneutral3/10GoldMining Inc. announced the commencement of a Pre-Feasibility Study and a 6,000-metre infill drilling program at its 1Oct 28, 2026
NBP6-Kneutral2/10NovaBridge Biosciences announced the appointment of Chuck Silberstein, M.D., M.B.A., CFA as its new Chief Financial OffiOct 28, 2026
AXGNPRESS-RELEASEbullish6/10Axogen reported Q3 2026 revenue of $75.8M (+26.2% YoY), beating the $73.2M consensus, and adjusted EPS of $0.21, well abOct 28, 2026
OGEPRESS-RELEASEbullish6/10OGE Energy reported Q3 2026 EPS of $1.52, beating the $1.37 consensus by 10.9%, and revenue of $1.18B, above the $1.12B Oct 28, 2026
GRMNPRESS-RELEASEbullish6/10Garmin reported record Q3 2026 revenue of $1.99B (+12% YoY) and GAAP EPS of $2.80 (+35% YoY), beating consensus estimateOct 28, 2026
ETSYPRESS-RELEASEbullish5/10Etsy reported Q3 2026 results with EPS of $0.84, beating the $0.74 consensus by 13.5%, and revenue of $668.1M, in line wOct 28, 2026
ADPPRESS-RELEASEbullish6/10ADP reported Q1 fiscal 2027 results with revenue of $5.49B (vs. $5.47B consensus) and adjusted diluted EPS of $2.82 (vs.Oct 28, 2026
SCLPRESS-RELEASEbullish6/10Stepan reported Q3 2026 adjusted EPS of $0.94, beating the $0.72 consensus by 30.6%, on net sales of $692.2M (+17% YoY),Oct 28, 2026
BLKBPRESS-RELEASEneutral5/10Blackbaud reported Q3 2026 non-GAAP diluted EPS of $1.36, beating the $1.33 consensus by 2.3%, and GAAP revenue of $292.Oct 28, 2026
MAS8-Kbullish6/10Masco reported Q3 2026 adjusted EPS of $1.19, above the $1.03 consensus, and revenue of $1.966B, above the $1.93B consenOct 28, 2026
IEX8-Kbullish6/10IDEX reported record Q3 2026 sales of $952M (+8% YoY) and record adjusted diluted EPS of $2.33 (+15% YoY), both ahead ofOct 28, 2026
« Previous Page 111 of 334 Next »